BioRegion Real Estate

Premium

Genentech Adds 500 Forbes Blvd. to South San Francisco Presence; Parent Roche Pulls Out of PhRMA

Genentech, the biotech pioneer headquartered in South San Francisco, Calif., has expanded its presence in its home city by agreeing to lease 156,000 square feet at 500 Forbes Blvd., the space formerly occupied by cancer therapy developer Cell Genesys, the San Francisco Business Times has reported.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.